Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
3
|
| pubmed:dateCreated |
1988-10-19
|
| pubmed:abstractText |
GL enzyme (hyaglosidase) is a highly purified component enzyme of hyaluronidase. A therapeutic trial was carried out in the treatment of suspected myocardial infarction among 1,488 patients presenting within 6 h of the onset of symptoms. No significant reduction in mortality at 6 months was observed in the GL group (15.7%) compared with the placebo group (16.4%). Mortality at 2 weeks was also unaffected by treatment (GL 10.3%; placebo 10.9%).
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0008-6312
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
75
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
177-83
|
| pubmed:dateRevised |
2007-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:3046747-Clinical Trials as Topic,
pubmed-meshheading:3046747-Female,
pubmed-meshheading:3046747-Follow-Up Studies,
pubmed-meshheading:3046747-Humans,
pubmed-meshheading:3046747-Hyaluronoglucosaminidase,
pubmed-meshheading:3046747-Male,
pubmed-meshheading:3046747-Middle Aged,
pubmed-meshheading:3046747-Myocardial Infarction,
pubmed-meshheading:3046747-Random Allocation,
pubmed-meshheading:3046747-Time Factors
|
| pubmed:year |
1988
|
| pubmed:articleTitle |
A controlled trial of GL enzyme in the treatment of acute myocardial infarction.
|
| pubmed:affiliation |
Freeman Hospital, Newcastle-upon-Tyne, UK.
|
| pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Controlled Clinical Trial
|